Ueda K - Search Results

1

Development of the rubella vaccine and vaccination strategy in Japan.

Ueda K. Ueda K. Vaccine. 2009 May 21;27(24):3232-3. doi: 10.1016/j.vaccine.2009.02.076. Vaccine. 2009. PMID: 19366581

2

Epidemiology of rubella and congenital rubella syndrome in Japan before 1989.

Ueda K. Ueda K. Vaccine. 2016 Apr 7;34(16):1971-4. doi: 10.1016/j.vaccine.2015.10.010. Epub 2015 Oct 23. Vaccine. 2016. PMID: 26469722 Review.

3

[Rubella and congenital rubella syndrome].

Ueda K. Ueda K. Nihon Rinsho. 2003 Feb;61 Suppl 2:173-8. Nihon Rinsho. 2003. PMID: 12722209 Review. Japanese. No abstract available.

4

A clinical phase I study of an EB66 cell-derived H5N1 pandemic vaccine adjuvanted with AS03.

Naruse T, Fukuda T, Tanabe T, Ichikawa M, Oda Y, Tochihara S, Kimachi K, Kino Y, Ueda K. Naruse T, et al. Among authors: ueda k. Vaccine. 2015 Nov 9;33(45):6078-84. doi: 10.1016/j.vaccine.2015.09.022. Epub 2015 Sep 25. Vaccine. 2015. PMID: 26409141 Clinical Trial.

5

[Rubella and congenital rubella syndrome].

Ueda K. Ueda K. Nihon Rinsho. 2007 Mar 28;65 Suppl 3:299-303. Nihon Rinsho. 2007. PMID: 17494156 Review. Japanese. No abstract available.

6

Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in healthy adults: a phase II, open-label, uncontrolled trial in Japan.

Tsurudome Y, Kimachi K, Okada Y, Matsuura K, Ooyama Y, Ibaragi K, Kino Y, Ueda K. Tsurudome Y, et al. Among authors: ueda k. Microbiol Immunol. 2015 Oct;59(10):597-604. doi: 10.1111/1348-0421.12316. Microbiol Immunol. 2015. PMID: 26272602 Free article. Clinical Trial.

7

The Immunogenicity and Safety Profile for KM-248, a Combined Measles, Mumps, and Rubella Vaccine, and Its Noninferiority to the Measles Vaccine in Healthy Japanese Children: a Phase 3 Randomized Multicenter Single-Blind Clinical Trial.

Platt H, Tochihara S, Oda Y, Ueda K. Platt H, et al. Among authors: ueda k. Jpn J Infect Dis. 2021 Sep 22;74(5):429-436. doi: 10.7883/yoken.JJID.2020.876. Epub 2021 Jan 29. Jpn J Infect Dis. 2021. PMID: 33518626 Free article. Clinical Trial.

8

Non-clinical and phase I clinical trials of a Vero cell-derived inactivated Japanese encephalitis vaccine.

Kuzuhara S, Nakamura H, Hayashida K, Obata J, Abe M, Sonoda K, Nishiyama K, Sugawara K, Takeda K, Honda T, Matsui H, Shigaki T, Kino Y, Mizokami H, Tanaka M, Mizuno K, Ueda K. Kuzuhara S, et al. Among authors: ueda k. Vaccine. 2003 Nov 7;21(31):4519-26. doi: 10.1016/s0264-410x(03)00506-1. Vaccine. 2003. PMID: 14575762 Clinical Trial.

9

Seroepidemiologic study on pertussis, diphtheria, and tetanus in the Fukuoka area of southern Japan: seroprevalence among persons 0-80 years old and vaccination program.

Okada K, Ueda K, Morokuma K, Kino Y, Tokugawa K, Nishima S. Okada K, et al. Among authors: ueda k. Jpn J Infect Dis. 2004 Apr;57(2):67-71. Jpn J Infect Dis. 2004. PMID: 15118214

10

Phase III clinical trials comparing the immunogenicity and safety of the vero cell-derived Japanese encephalitis vaccine Encevac with those of mouse brain-derived vaccine by using the Beijing-1 strain.

Miyazaki C, Okada K, Ozaki T, Hirose M, Iribe K, Yokote H, Ishikawa Y, Togashi T, Ueda K. Miyazaki C, et al. Among authors: ueda k. Clin Vaccine Immunol. 2014 Feb;21(2):188-95. doi: 10.1128/CVI.00377-13. Epub 2013 Dec 11. Clin Vaccine Immunol. 2014. PMID: 24334689 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,443 results

Search Page